Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04298034 · ClinicalTrials.gov registry record · Phase 3
Preeclampsia Postpartum Antihypertensive Treatment
A Phase 3 study of Preeclampsia and Hypertension in Pregnancy, sponsored by Medical College of Wisconsin.
- Active
- Registry status
- Phase 3
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT04298034: Active Phase 3 study of Preeclampsia and Hypertension in Pregnancy, sponsored by Medical College of Wisconsin.
NCT04298034 is a Phase 3 study of Preeclampsia and Hypertension in Pregnancy that is active but no longer recruiting, run by Medical College of Wisconsin. The registered enrollment target is 300 participants, below the 1,120-participant average among 48 other Preeclampsia trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04298034, a Phase 3 study of Preeclampsia and Hypertension in Pregnancy, is active but no longer recruiting, sponsored by Medical College of Wisconsin.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 3
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to compare whether antihypertensive treatment in the postpartum period decreases postpartum hypertension and its associated maternal morbidity, including risk of readmission and healthcare utilization in comparison with no treatment. Women with preeclampsia diagnosed during the antepartum, intrapartum or postpartum period will be randomized to either initiate antihypertensive treatment or standard of care. We hypothesize that postpartum antihypertensive treatment of patients with preeclampsia will decrease risk of hospital readmission, healthcare utilization and the number of severe range blood pressures at postpartum follow-up visits.
Conditions Studied
Interventions
- DRUG Labetalol, Nifedipine
Study Locations (1)
Wisconsin
- Medical College of Wisconsin-Froedtert Hospital - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2020-07-17 |
| Est. Completion | 2025-12-30 |
| Phase | Phase 3 |
What the registry record for NCT04298034 still lists
NCT04298034 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 1,120-participant average among 48 other Preeclampsia trials with a reported enrollment target (73% lower).
The record links to 2 conditions, with Preeclampsia appearing as the primary indexed condition, and to 1 intervention - of which Labetalol, Nifedipine is the first listed.
NCT04298034 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT04298034 about?
NCT04298034 is a clinical study titled "Preeclampsia Postpartum Antihypertensive Treatment". The goal of this study is to compare whether antihypertensive treatment in the postpartum period decreases postpartum hypertension and its associated maternal morbidity, including risk of readmission and healthcare utilization in comparison with no treatment. Women with preeclampsia diagnosed during...
What is the current status of trial NCT04298034?
This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 300 participants. The study started on 2020-07-17. Estimated completion is 2025-12-30.
What conditions does trial NCT04298034 study?
This clinical trial studies the following conditions: Preeclampsia, Hypertension in Pregnancy.
What interventions are being tested in trial NCT04298034?
The interventions under investigation include: Labetalol, Nifedipine (DRUG).
Who is sponsoring clinical trial NCT04298034?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04298034 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Preeclampsia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04298034's enrollment target sits among peer trials
300 15th of 48 higher than 34 of 48 other Preeclampsia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Preeclampsia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia
RECRUITING · Phase 3
-
Natural Versus Programmed Frozen Embryo Transfer (NatPro)
ACTIVE NOT RECRUITING · Phase 3
-
Spironolactone to Improve Pregnancy-Associated Hypertension Trajectories
RECRUITING · Phase 2
-
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
RECRUITING · NA
-
Daily Aspirin Treatment After Preeclampsia
RECRUITING · Early Phase 1
-
Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI